A1421 AHU377+valsartan (LCZ696) Modulates RAS Components in the Cardiac and Aorta of Female Spontaneously Hypertensive Rats Compared with Valsartan
Zhao Yang,RuiXin Ma,Xiaorong Yu,Ningyin Li,Heng Yu,Xu Zhao,Han Xu,Ruowen Yuan,Xiaowei Zhang,Wei Liang,Jing Yu
DOI: https://doi.org/10.1097/01.hjh.0000548043.03145.4c
IF: 4.9
2018-01-01
Journal of Hypertension
Abstract:Objectives: The Renin Angiotensin System (RAS) plays an important role in the pathophysiology of hypertension. LCZ696, a first-in-class drug which comprises the ARB valsartan and angiotensin receptor neprilysin (NEP) inhibitor (ARNi). The main goal of the present study was to evaluate the protein and gene expression of the RAS components in the cardiac and aorta tissue of female spontaneously hypertensive rats. Methods: Sixteen-week-old female normotensive Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) were used in this study. Tail-cuff method was performed to measure the blood pressure of SHR. WKY and SHR rats were randomly devided to LCZ696 group (n = 10), valsartan group (n = 10), SHR control group (n = 10) and WKY control group (n = 10). Body and aorta weight were record after treated with LCZ696 and valsartan. Animals were then euthanized, cardiac and aorta were analyzed for the expression of ACE, ACE2, AT1R, AT2R and MasR by real-time PCR, western blot and immunhistochemical (IHC). Results: There were significantly greater reductions in systolic and diastolic blood pressure between AHU377+valsartan and valsartan. LCZ696 not only inhibited the increase in ACE and AT1R protein expression in the cardiac and aorta of SHR, but also significantly upregulated ACE2 and MasR receptor expression in SHR. In addition, compared with valsartan, LCZ696 showed greater degree in reduce inducible NO synthase and endothelial NO synthase. Conclusion: Our data suggested that the inhibition on ACE/angiotensin-II/ AT1R axis is intensified when combined AHU377 + valsartan (LCZ696) with valsartan in cardiac of SHR. These results suggest that AHU377+valsartan (LCZ696) improve the protective pathway in the cardiac and aorta tissue of SHR, at least partially, explain the greater hypotensive effect of LCZ696 in SHR.